|
|
 |
|
| | |
| | | | | |
gene
|
|
PR:000011209 |
nidogen-2
|
NID2
|
"A protein that is a translation product of the human NID2 gene or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:B5DFC9 |
nidogen-2 (rat)
|
rNID2
|
"A nidogen-2 that is encoded in the genome of rat." [OMA:B5DFC9, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:B5DFC9-1 |
nidogen-2 isoform r1 (rat)
|
rNID2/iso:r1
|
"A nidogen-2 (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:B5DFC9-1." [PRO:DNx, UniProtKB:B5DFC9]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:B5DFC9-2 |
nidogen-2 isoform r2 (rat)
|
rNID2/iso:r2
|
"A nidogen-2 (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:B5DFC9-2." [PRO:DNx, UniProtKB:B5DFC9]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058554 |
nidogen-2 N-glycosylated 1 (rat)
|
rNID2/NGlyco:1
|
"A nidogen-2 (rat) that has been N-glycosylated at the residue equivalent to Asn-719 of the amino acid sequence represented by UniProtKB:B5DFC9-1, in which the glycan structure is represented by GlyTouCan:G30159WR. Example: UniProtKB:B5DFC9-1, Asn-719, MOD:00160~GNO:G30159WR." [GlyGen:B5DFC9-1, PMID:24090084, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000058555 |
nidogen-2 N-glycosylated 2 (rat)
|
rNID2/NGlyco:2
|
"A nidogen-2 (rat) that has been N-glycosylated at the residue equivalent to Asn-719 of the amino acid sequence represented by UniProtKB:B5DFC9-1, in which the glycan composition is represented by GlyTouCan:G88725PI. Example: UniProtKB:B5DFC9-1, Asn-719, MOD:00160~GNO:G88725PI." [GlyGen:B5DFC9-1, PMID:24090084, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:O88322 |
nidogen-2 (mouse)
|
mNID2
|
"A nidogen-2 that is encoded in the genome of mouse." [OMA:O88322, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:Q14112 |
nidogen-2 (human)
|
hNID2
|
"A nidogen-2 that is encoded in the genome of human." [PRO:DNx, UniProtKB:Q14112]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:Q14112-1 |
nidogen-2 isoform h1 (human)
|
hNID2/iso:h1
|
"A nidogen-2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14112-1." [PRO:DNx, UniProtKB:Q14112]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-sequence
|
|
PR:Q14112-2 |
nidogen-2 isoform h2 (human)
|
hNID2/iso:h2
|
"A nidogen-2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14112-2." [PRO:DNx, UniProtKB:Q14112]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000048605 |
nidogen-2, signal peptide removed form (human)
|
hNID2/SigPep-
|
"A nidogen-2 (human) that has had the signal peptide removed. UniProtKB:Q14112, 31-1375." [PRO:DNx, Reactome:R-HSA-388751]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057071 |
nidogen-2 O-glycosylated 1 (human)
|
hNID2/OGlyco:1
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-359 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q14112-1, Ser-359, MOD:00002~GNO:G53434XO." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057072 |
nidogen-2 O-glycosylated 2 (human)
|
hNID2/OGlyco:2
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-359 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:Q14112-1, Ser-359, MOD:00002~GNO:G58001LT." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057073 |
nidogen-2 O-glycosylated 3 (human)
|
hNID2/OGlyco:3
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-370 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Ser-370, MOD:00002~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057074 |
nidogen-2 O-glycosylated 4 (human)
|
hNID2/OGlyco:4
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-370 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Ser-370, MOD:00002~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057075 |
nidogen-2 O-glycosylated 5 (human)
|
hNID2/OGlyco:5
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-393 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Ser-393, MOD:00002~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057076 |
nidogen-2 O-glycosylated 6 (human)
|
hNID2/OGlyco:6
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-393 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Ser-393, MOD:00002~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057077 |
nidogen-2 O-glycosylated 7 (human)
|
hNID2/OGlyco:7
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-419 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G27391WQ. Example: UniProtKB:Q14112-1, Ser-419, MOD:00002~GNO:G27391WQ." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057078 |
nidogen-2 O-glycosylated 8 (human)
|
hNID2/OGlyco:8
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-419 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Ser-419, MOD:00002~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057079 |
nidogen-2 O-glycosylated 9 (human)
|
hNID2/OGlyco:9
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-419 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Ser-419, MOD:00002~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057080 |
nidogen-2 O-glycosylated 10 (human)
|
hNID2/OGlyco:10
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-431 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Ser-431, MOD:00002~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057081 |
nidogen-2 O-glycosylated 11 (human)
|
hNID2/OGlyco:11
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Ser-448 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Ser-448, MOD:00002~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057082 |
nidogen-2 O-glycosylated 12 (human)
|
hNID2/OGlyco:12
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1012 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Thr-1012, MOD:00005~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057083 |
nidogen-2 O-glycosylated 13 (human)
|
hNID2/OGlyco:13
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1012 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-1012, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057084 |
nidogen-2 O-glycosylated 14 (human)
|
hNID2/OGlyco:14
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1087 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Thr-1087, MOD:00005~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057085 |
nidogen-2 O-glycosylated 15 (human)
|
hNID2/OGlyco:15
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1087 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-1087, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057086 |
nidogen-2 O-glycosylated 16 (human)
|
hNID2/OGlyco:16
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1096 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G27391WQ. Example: UniProtKB:Q14112-1, Thr-1096, MOD:00005~GNO:G27391WQ." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057087 |
nidogen-2 O-glycosylated 17 (human)
|
hNID2/OGlyco:17
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1096 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Thr-1096, MOD:00005~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057088 |
nidogen-2 O-glycosylated 18 (human)
|
hNID2/OGlyco:18
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1096 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-1096, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057089 |
nidogen-2 O-glycosylated 19 (human)
|
hNID2/OGlyco:19
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1096 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q14112-1, Thr-1096, MOD:00005~GNO:G53434XO." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057090 |
nidogen-2 O-glycosylated 20 (human)
|
hNID2/OGlyco:20
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1096 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:Q14112-1, Thr-1096, MOD:00005~GNO:G58001LT." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057091 |
nidogen-2 O-glycosylated 21 (human)
|
hNID2/OGlyco:21
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1096 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G73004SD. Example: UniProtKB:Q14112-1, Thr-1096, MOD:00005~GNO:G73004SD." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057092 |
nidogen-2 O-glycosylated 22 (human)
|
hNID2/OGlyco:22
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1096 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G88713AC. Example: UniProtKB:Q14112-1, Thr-1096, MOD:00005~GNO:G88713AC." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057093 |
nidogen-2 O-glycosylated 23 (human)
|
hNID2/OGlyco:23
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1102 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:Q14112-1, Thr-1102, MOD:00005~GNO:G58001LT." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057094 |
nidogen-2 O-glycosylated 24 (human)
|
hNID2/OGlyco:24
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-1113 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Thr-1113, MOD:00005~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057095 |
nidogen-2 O-glycosylated 25 (human)
|
hNID2/OGlyco:25
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-365 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Thr-365, MOD:00005~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057096 |
nidogen-2 O-glycosylated 26 (human)
|
hNID2/OGlyco:26
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-365 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-365, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057097 |
nidogen-2 O-glycosylated 27 (human)
|
hNID2/OGlyco:27
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-369 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G27391WQ. Example: UniProtKB:Q14112-1, Thr-369, MOD:00005~GNO:G27391WQ." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057098 |
nidogen-2 O-glycosylated 28 (human)
|
hNID2/OGlyco:28
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-369 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Thr-369, MOD:00005~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057099 |
nidogen-2 O-glycosylated 29 (human)
|
hNID2/OGlyco:29
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-369 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-369, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057100 |
nidogen-2 O-glycosylated 30 (human)
|
hNID2/OGlyco:30
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-369 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q14112-1, Thr-369, MOD:00005~GNO:G53434XO." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057101 |
nidogen-2 O-glycosylated 31 (human)
|
hNID2/OGlyco:31
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-369 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:Q14112-1, Thr-369, MOD:00005~GNO:G58001LT." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057102 |
nidogen-2 O-glycosylated 32 (human)
|
hNID2/OGlyco:32
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-391 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Thr-391, MOD:00005~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057103 |
nidogen-2 O-glycosylated 33 (human)
|
hNID2/OGlyco:33
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-391 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-391, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057104 |
nidogen-2 O-glycosylated 34 (human)
|
hNID2/OGlyco:34
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-410 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Thr-410, MOD:00005~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057105 |
nidogen-2 O-glycosylated 35 (human)
|
hNID2/OGlyco:35
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-410 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-410, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057106 |
nidogen-2 O-glycosylated 36 (human)
|
hNID2/OGlyco:36
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-410 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q14112-1, Thr-410, MOD:00005~GNO:G53434XO." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057107 |
nidogen-2 O-glycosylated 37 (human)
|
hNID2/OGlyco:37
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-462 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-462, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057108 |
nidogen-2 O-glycosylated 38 (human)
|
hNID2/OGlyco:38
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-475 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q14112-1, Thr-475, MOD:00005~GNO:G29068FM." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057109 |
nidogen-2 O-glycosylated 39 (human)
|
hNID2/OGlyco:39
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-475 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-475, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057110 |
nidogen-2 O-glycosylated 40 (human)
|
hNID2/OGlyco:40
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-479 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-479, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057111 |
nidogen-2 O-glycosylated 41 (human)
|
hNID2/OGlyco:41
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-846 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-846, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057112 |
nidogen-2 O-glycosylated 42 (human)
|
hNID2/OGlyco:42
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-934 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-934, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057113 |
nidogen-2 O-glycosylated 43 (human)
|
hNID2/OGlyco:43
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-994 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q14112-1, Thr-994, MOD:00005~GNO:G43417UB." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057114 |
nidogen-2 O-glycosylated 44 (human)
|
hNID2/OGlyco:44
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-994 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q14112-1, Thr-994, MOD:00005~GNO:G53434XO." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000057115 |
nidogen-2 O-glycosylated 45 (human)
|
hNID2/OGlyco:45
|
"A nidogen-2 (human) that has been O-glycosylated at the residue equivalent to Thr-994 of the amino acid sequence represented by UniProtKB:Q14112-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:Q14112-1, Thr-994, MOD:00005~GNO:G58001LT." [GlyGen:Q14112-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
modification
|
|
PR:000020743 |
nidogen-2, signal peptide removed form
|
NID2/SigPep-
|
"A nidogen-2 that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000048605 |
nidogen-2, signal peptide removed form (human)
|
hNID2/SigPep-
|
"A nidogen-2 (human) that has had the signal peptide removed. UniProtKB:Q14112, 31-1375." [PRO:DNx, Reactome:R-HSA-388751]
|
|
|
|
|
